ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Taiho signs drug licensing deal with Lung Therapeutics in Japan
November 13, 2020Taiho Pharmaceutical has entered an exclusive licence agreement with Lung Therapeutics for the latter’s investigational recombinant human single-chain urokinase plasminogen activator, LTI-01, in Japan. -
Taiho Pharmaceutical licences lung cancer drug to Cullinan Oncology
February 20, 2019Japan-based Taiho Pharmaceutical has signed an agreement to licence its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidate TAS6417 for lung cancer to Cullinan Oncology.... -
Japan's Taiho Pharmaceutical Announces Expansion into Canada
March 09, 2017Taiho Pharmaceutical Co has established its subsidiary Taiho Pharma Canada, Inc. inOakville, Ontario. The Canadian operations will be managed by Taiho Oncology, Inc., the U.S. R&D and commercial operations of the Taiho Group, based in Princeton, N.J.
Pharma Sources Insight January 2025
